Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.

Dutta P, Funston W, Mossop H, Ryan V, Jones R, Forbes R, Sen S, Pearson J, Griffin SM, Smith JA, Ward C, Forrest IA, Simpson AJ.

Thorax. 2019 Apr;74(4):346-353. doi: 10.1136/thoraxjnl-2018-212102. Epub 2019 Jan 4.

2.

Reflux in idiopathic pulmonary fibrosis: treatment informed by an integrated approach.

Jones R, Krishnan A, Zeybel GL, Dookun E, Pearson JP, Simpson AJ, Griffin SM, Ward C, Forrest IA.

ERJ Open Res. 2018 Nov 5;4(4). pii: 00051-2018. doi: 10.1183/23120541.00051-2018. eCollection 2018 Oct.

3.

IPF: time for the (ciliary) beat generation?

Wiscombe S, Forrest IA, Simpson AJ.

Thorax. 2013 Dec;68(12):1088-9. doi: 10.1136/thoraxjnl-2013-203928. Epub 2013 Sep 4. No abstract available.

PMID:
24005445
4.

Macrolide antibiotics and the airway: antibiotic or non-antibiotic effects?

Murphy DM, Forrest IA, Curran D, Ward C.

Expert Opin Investig Drugs. 2010 Mar;19(3):401-14. doi: 10.1517/13543781003636480. Review.

PMID:
20151856
5.

Are clinical parameters and biomarkers predictive of severity of acute pulmonary emboli on CTPA?

Jeebun V, Doe SJ, Singh L, Worthy SA, Forrest IA.

QJM. 2010 Feb;103(2):91-7. doi: 10.1093/qjmed/hcp162. Epub 2009 Dec 29.

PMID:
20040533
6.

Sarcoidosis: an underrecognised cause for bullous lung disease?

Jeebun V, Forrest IA.

Eur Respir J. 2009 Oct;34(4):999-1001. doi: 10.1183/09031936.00084609. No abstract available.

7.

Targeting allograft injury and inflammation in the management of post-lung transplant bronchiolitis obliterans syndrome.

Robertson AG, Griffin SM, Murphy DM, Pearson JP, Forrest IA, Dark JH, Corris PA, Ward C.

Am J Transplant. 2009 Jun;9(6):1272-8. doi: 10.1111/j.1600-6143.2009.02648.x. Epub 2009 May 20. Review.

8.

Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells.

Murphy DM, Forrest IA, Corris PA, Johnson GE, Small T, Jones D, Fisher AJ, Egan JJ, Cawston TE, Lordan JL, Ward C.

J Heart Lung Transplant. 2008 Nov;27(11):1210-6. doi: 10.1016/j.healun.2008.07.026. Epub 2008 Oct 1.

PMID:
18971093
9.

Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome.

Anderson RL, Hiemstra PS, Ward C, Forrest IA, Murphy D, Proud D, Lordan J, Corris PA, Fisher AJ.

Eur Respir J. 2008 Sep;32(3):670-7. doi: 10.1183/09031936.00110807. Epub 2008 May 28.

10.

Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients.

Murphy DM, Forrest IA, Corris PA, Johnson GE, Small T, Jones D, Fisher AJ, Egan JJ, Cawston TE, Ward C, Lordan JL.

Am J Physiol Lung Cell Mol Physiol. 2008 Mar;294(3):L592-9. doi: 10.1152/ajplung.00386.2007. Epub 2008 Jan 18.

11.

Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts.

Murphy DM, Forrest IA, Ward C, Corris PA, Johnson GE, Jones D, Fisher AJ, Egan JJ, Cawston TE, Lordan JL.

Thorax. 2007 Sep;62(9):834. No abstract available.

12.

Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection.

Stovold R, Forrest IA, Corris PA, Murphy DM, Smith JA, Decalmer S, Johnson GE, Dark JH, Pearson JP, Ward C.

Am J Respir Crit Care Med. 2007 Jun 15;175(12):1298-303. Epub 2007 Apr 5.

PMID:
17413126
13.

The phosphodiesterase type IV inhibitor cilomilast decreases pro-inflammatory cytokine production from primary bronchial epithelial cells in lung transplantation patients.

Murphy DM, Ward C, Forrest IA, Pritchard G, Jones D, Stovold R, Fisher AJ, Cawston TE, Lordan JL, Corris PA.

J Heart Lung Transplant. 2006 Dec;25(12):1436-40.

PMID:
17178338
14.

Primary airway epithelial cell culture from lung transplant recipients.

Forrest IA, Murphy DM, Ward C, Jones D, Johnson GE, Archer L, Gould FK, Cawston TE, Lordan JL, Corris PA.

Eur Respir J. 2005 Dec;26(6):1080-5.

15.

Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts.

Ward C, Forrest IA, Brownlee IA, Johnson GE, Murphy DM, Pearson JP, Dark JH, Corris PA.

Thorax. 2005 Oct;60(10):872-4. Epub 2005 Jul 29.

16.

Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.

Yates B, Murphy DM, Forrest IA, Ward C, Rutherford RM, Fisher AJ, Lordan JL, Dark JH, Corris PA.

Am J Respir Crit Care Med. 2005 Sep 15;172(6):772-5. Epub 2005 Jun 23.

PMID:
15976371
17.

Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients.

Ward C, Forrest IA, Murphy DM, Johnson GE, Robertson H, Cawston TE, Fisher AJ, Dark JH, Lordan JL, Kirby JA, Corris PA.

Thorax. 2005 Oct;60(10):865-71. Epub 2005 Jun 21.

18.

Hypothesis: epithelial-to-mesenchymal transition is a common cause of chronic allograft failure.

Ward C, Robertson H, Forrest IA, Lordan J, Murphy D, Dark JH, Corris PA, Jones DE, Kirby JA.

Transplant Proc. 2005 Mar;37(2):977-80. Review.

PMID:
15848596
19.

Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids.

Ward C, De Soyza A, Fisher AJ, Pritchard G, Forrest IA, Corris PA.

Clin Exp Allergy. 2004 Dec;34(12):1905-9.

PMID:
15663566
21.

The effect of an acute load of glucose on the rate of clearance of lactate from the blood of adult males after severe exercise.

Forrest IA, Adams SA, Nimmo IA, Saunders DH, Stewart AD.

Biochem Soc Trans. 1991 Apr;19(2):132S. No abstract available.

PMID:
1889532

Supplemental Content

Loading ...
Support Center